Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials
Crossref DOI link: https://doi.org/10.1007/s11136-016-1288-4
Published Online: 2016-04-15
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koukakis, Reija
Gatta, Francesca
Hechmati, Guy
Siena, Salvatore
Funding for this research was provided by:
Amgen Inc
License valid from 2016-04-15